Lilly and Incyte shoot for FDA approval with an oral RA drug

Damian Garde

Partners Eli and filed an rheumatoid arthritis treatment for FDA , hoping to launch an agent that can steal market share from blockbuster injectables.

FierceBiotech News

Share This Post

Related Articles

Leave a Reply

© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS